Risankizumab 68225-0233-00
- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- June 16, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 150 mg/mL |
Selected Package
68225-0233-00Selected1 CARTRIDGE in 1 CARTON (68225-233-00) / 1.2 mL in 1 CARTRIDGE